Pharma Focus Asia

HemoShear Therapeutics Enters into Rare Liver Disease Research Collaboration with Takeda

Thursday, October 22, 2020

HemoShear Therapeutics, LLC, a privately held clinical stage biotechnology company, has entered into a research collaboration and service agreement with Takeda Pharmaceutical Company Limited ("Takeda"). Under the terms of the agreement, HemoShear will receive an upfront payment and funding to develop a new human tissue-based model of a rare liver disease using the company's REVEAL-Tx™ Platform. REVEAL-Tx™ combines physiological and computational models of disease to identify novel treatment approaches and select drug candidates in a human-relevant disease context. 

HemoShear has a successful ongoing three-year collaboration with Takeda to discover and develop novel therapeutics for liver diseases, including nonalcoholic steatohepatitis (NASH).

"We are excited to expand our collaboration with Takeda into modeling rare liver diseases," said Brian Wamhoff, PhD, chief operating officer and head of innovation, HemoShear. "Our unique ability to recreate models of complex rare diseases will enable Takeda to interrogate their drug targets in the genetic background of human disease and select lead candidates in an accelerated timeframe."

"We have identified and validated innovative targets through our existing partnership with HemoShear that we continue to explore in early research," said Gareth Hicks, Ph.D., GI Drug Discovery Unit Head at Takeda. "This new collaboration gives us the opportunity to build on that momentum and expand the reach of our combined expertise to a challenging, severe rare liver disease of high unmet need."

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024